Further studies discovered that targeting CtBP results in the increased tumor cell apoptosis owing to the breakdown of pH homeostasis in engrafted tumors, suggesting that CtBP can be a potential therapeutic target for breast cancer treatment. This evidence concerns the gene CTBP1 and breast carcinoma.